Loading...

PR Information Data

130 개 6 페이지
번호 컨텐츠
55 Challenge the global medical device market with proven clinical effects : 2019.02.01 HOT 2019-02-01   3138 (주)아디포랩스
54 "AdipoLABs supports MOU between Dae-jeon University's Seoul Oriental Hospital and the United World Halal Development" : 2019.11.22 HOT 2019-11-22   3094 (주)아디포랩스
53 AdipoLABs receives 'Industrial Grand Prize for 3 consecutive years' : 2019.03.08 HOT 2019-03-08   3088 (주)아디포랩스
52 [Reporter Hong's FoodToday] Medical staff and scholars from 30 countries around the world gathered... International collaborative organization 'IVRA' launched 2024-02-21   78 (주)아디포랩스
51 AdipoLABs, selected as ‘First in Class’ hyperthermia cancer treatment device 2024-02-16   73 (주)아디포랩스
50 Establishment of IVRA with medical staff from 30 countries, “preparation of coronavirus treatment measures” 2024-02-21   68 (주)아디포랩스
49 AdipoLABs’ high-frequency device ‘REMISSION 1℃’ is being exported to Europe 2024-02-15   66 (주)아디포랩스
48 International conference ‘IVRA’ held to share hope in medical care to overcome COVID-19 2024-02-21   65 (주)아디포랩스
47 AdipoLABs, high-frequency hyperthermia cancer treatment device with a REMISSION 1℃, receives European certification and Malaysian MDA approval 2024-02-16   62 (주)아디포랩스
46 COVID-19 new treatment method ‘hyperthermia treatment device’… Research begins in earnest with launch of IVRA 2024-02-21   62 (주)아디포랩스
45 Research on cancer immunotherapy effects of high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ begins in earnest 2024-02-16   60 (주)아디포랩스
44 Overcoming the COVID-19 pandemic, we host a stage for sharing medical care 2024-02-21   60 (주)아디포랩스
43 AdipoLABs’ ‘practice of love that transcends borders 2024-02-16   57 (주)아디포랩스
42 IVRA draws attention to presenting a new medical paradigm to overcome COVID-19 2024-02-21   57 (주)아디포랩스
41 “There are trials, but there are no failures” AdipoLABs’ CE success story 2024-02-15   51 (주)아디포랩스